VAERS reports by lot

Moderna COVID-19 lot 001J21-2A: VAERS reports

158 VAERS reports list lot 001J21-2A as a Moderna COVID-19 vaccine, received between 2022-01-06 and 2024-07-18. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
158
Reports
14%
Marked serious
3
With a death outcome
12
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)6420%
Cardiac / Cardiovascular5718%
Neurological5317%
Gastrointestinal3110%
Respiratory258%
Injection-site / Local reaction206%
Musculoskeletal165%
Dermatological (non-injection-site)144%
Allergic / Anaphylactic124%
Thrombotic / Hematological93%
Autoimmune / Immune-mediated72%
Psychiatric / Neuropsychiatric62%
Reproductive / Menstrual10%

Where reports came from

U.S. state of the reporter, where given (top 12).

Texas29
Puerto Rico15
Oregon10
Kansas8
Iowa7
California7
Wisconsin7
Michigan7
Minnesota6
New York5
Florida5
Pennsylvania4

Reports by month received

2022-0148
2022-0253
2022-0327
2022-0416
2022-052
2022-073
2022-081
2022-093
2022-121
2023-032
2023-111
2024-071

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.